Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 92,999 | 105,595 | 75,081 | 71,359 | 64,779 |
| Cost of Goods | 21,053 | 20,930 | 22,765 | 28,989 | 26,784 |
| Gross Profit | 71,946 | 84,665 | 52,316 | 42,370 | 37,995 |
| Operating Expenses | 23,865 | 24,148 | 20,474 | 23,643 | 24,811 |
| Operating Income | 48,134 | 61,447 | 32,607 | 19,715 | 13,967 |
| Other Income | 120 | 58 | -127 | -188 | -182 |
| Pre-tax Income | 48,254 | 61,505 | 32,480 | 19,527 | 13,785 |
| Income Tax | 17,496 | 23,186 | 11,905 | 7,770 | 5,318 |
| Net Income Continuous | 30,758 | 38,319 | 20,575 | 11,758 | 8,467 |
| Net Income | $30,758 | $38,319 | $20,575 | $11,758 | $8,467 |
| EPS Basic Total Ops | 2.06 | 2.61 | 1.46 | 0.89 | 0.65 |
| EPS Basic Continuous Ops | 2.06 | 2.61 | 1.46 | 0.89 | 0.65 |
| EPS Diluted Total Ops | 2.01 | 2.51 | 1.39 | 0.82 | 0.62 |
| EPS Diluted Continuous Ops | 2.01 | 2.51 | 1.39 | 0.82 | 0.62 |
| EBITDA(a) | $51,909 | $66,153 | $37,379 | $24,241 | $17,970 |